Form D — Ensho Therapeutics, Inc.
0002032849-26-000001 · filed Feb 9, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $20,000,000
- Reported amount sold
- $0
- Minimum investment
- $1
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ensho Therapeutics, Inc.
- CIK
- 2032849
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 50 Tice Boulevard
Woodcliff Lake, New Jersey 07677 - Phone
- 973-475-8970
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Danielle Fry · Executive OfficerWoodcliff Lake, New Jersey Find on LinkedIn ↗
-
Arash Rassoulpour · DirectorWoodcliff Lake, New Jersey Find on LinkedIn ↗
-
Carlos Solorzano · DirectorWoodcliff Lake, New Jersey Find on LinkedIn ↗
-
Eric Pham · DirectorWoodcliff Lake, New Jersey Find on LinkedIn ↗
-
Gerhard Hagn · Executive OfficerWoodcliff Lake, New Jersey Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗